Biosketch

Dr. Ronald Neumann, a native of Watertown, Wisconsin, earned his bachelor’s degree from Carroll College in Waukesha, Wisconsin, and his medical degree from Yale University. He stayed on at Yale for residencies in pathology and nuclear medicine.

While teaching and practicing nuclear medicine at Yale, Dr. Neumann also served as acting chief of nuclear medicine at the Department of Veterans Affairs Medical Center in West Haven, Connecticut. He came to the National Institutes of Health in 1985 as deputy chief of the Clinical Center’s Nuclear Medicine Department. He has been chief of the department since 1988, and, since 1998, has also held a dual appointment as deputy associate director for imaging sciences.

Dr. Neumann’s research has focused on developing nuclear medicine tests and treatments for cancer patients. In addition to his CC duties, Dr. Neumann served in the mid-1990s as a senior policy analyst on the White House Advisory Committee on Human Radiation Experiments. He also has been a clinical professor of diagnostic radiology at George Washington University School of Medicine since 1986.

Selected Honors and Awards

Carroll College Distinguished Alumnus Award for Professional Achievement 2003; Fellow, American College of Chest Physicians; president, 1998, mid-Atlantic chapter, Society of Nuclear Medicine; CC representative, NIH Medical Board, 1993-1995.

Selected Publications

BOOKS AND BOOK CHAPTERS

Baum BJ, Fox FC, Neumann RD: The Salivary Glands, pp 439-444, in Nuclear Medicine Diagnosis and Therapy, J Harbert, WC Eckelman, RD Neumann (eds), 1996.

Neumann RD (Associate Editor) Yearbook of Nuclear Medicine, 1996.

Neumann RD (Associate Editor) Yearbook of Nuclear Medicine, 1997.

Neumann RD, Carrasquillo JA, Weiner RE, Falen SW, Kemp JD, Chen CC: Radionuclide Imaging, pp 555-576, in Non-Hodgkin’s Lymphomas-2nd Edition, Ian Magrath (ed), Arnold, 1997.

Neumann RD, Ferrand SK, Chen CC, Dilsizian V: What’s New in Nuclear Medicine Imaging, in Surgical Oncology Clinics of North America. W.B. Saunders Company, January 1999.

Caride VJ, Cooper DL, Neumann RD: A Critical Assessment of the Prognostic Value of Gallium-67 Scintigraphy in Lymphoma, in Nuclear Medicine Annual, LM Freeman (ed), 1999.

Goldsmith SJ, Bar-Shalom R, Kostakoglue L, Neumann RD, Kemp JD, Weiner RE: Gallium-67 Imaging for Detection of Malignant Disease, pp 913-930, In Diagnostic Nuclear Medicine, - 4TH Edition, M Sandler, RE Coleman, JA Patton, FJ Th Wackers; A Gottschalk, (eds), Lippincott Williams & Wilkins, Philadelphia, 2003.

Neumann RD, McAfee JG: Gallium-67 Imaging in Infection, pp 1205-1218, in Diagnostic Nuclear Medicine, - 4TH Edition, M Sandler, RE Coleman, JA Patton, FJ Th Wackers; A Gottschalk, (eds), Lippincott Williams & Wilkins, Philadelphia, 2003

Neumann RD, Feinendegen L, Panyutin I, Winters T: Chap. 28 Development of DNA based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. pp 697-712; Feinendegen, et al (eds) in Molecular Nuclear Medicine – The Challenge of Genomics and Proteomics, Springer, Berlin, 2003.

Carrasquillo JA, Weiner RE, McAreavey D, Neumann RD: Radionuclide Tests, eds: .Magrath; Chapter 50; The Lymphoid Neoplasms, Hodder Arnold, London, 2006.

JOURNAL ARTICLES

He Y, Panyutin IG, Karavanov A, Demidov VV, Neumann RD. Sequence-specific DNA strand cleavage by 111In-labeled peptide nucleic acids. Europ J. Nuc Med/Mol Imag. 31: 837-845, 2004.

Sedelikova OA, Panyutin IV, Neumann RD, Bonner WM, Panyutin IG: Assessment of DNA damage produced by 125I-triplex forming oligonucleotides in cells. Internat Jr of Rad Biol 80 (11-12); 927-931, 2004.

He Y, Neumann RD, Panyutin I: Intramolecular Quadruplex conformation of human telomeric DNA assessed with Iodine-125 radioprobing. Nucleic Acids Res. Sept 32 (18); 5359-5367, 2004.

Feinendegen LE, Neumann RD: Dosimetry and risk from low- versus high-LET radiation of Auger events and the role of nuclide carriers. Int. J. Radiat. Biol, 80 (11-12); 813-822; 2004.

Gaidamakova EK, Neumann RD, Panyutin IG: Antisense Radiotherapy; Targeting Full-Size mdrl mRNA with 125I-labeled Oligonucleotides. Int J Radiot Biol 80: 889-893; 2004.

Datta K, Neumann RD, Winters TA: Characterization of a Complex 125I-induced DNA Double-Strand Break: Implications for Repair. Int. J Radia. Biol 81 (1): 13-21; 2005.

Datta K, Neumann RD, Wintrs TA: Characterization of complex apurinic/apyrimidinic-site clustering associated with an authentic site-specific radiation-induced DNA double-strand break. PNAS, USA, 102(30): 10569-10574; 2005.

Feinendegen LE, Neumann RD: Physics Must Join with Biology in Better Assessing Risk from Low-Dose Irradiation. Rad Protec Dosimetry 2005.

Sokolov, MV, Smilenov, LB, Hall, EF, Panyutin IG, Bonner, WM, Sedelnikova, OA. Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene 24: 7257-7265; 2005.

Panyutin IG, Neumann, RD: The potential for gene-targeted radiation therapy of cancers. Trends in Biotechology, 23: 492-496; 2005.

Panyutin IV, Sedelnikova OA, Bonner WM, Panyutin IG, Neumann RD: DNA Damage Produced by 125I-Tripolex-Forming Oligonucleotides as a Measure of Their Succesful Delivery into Cell Nuclei. Ann N Y Acad Sci. Nov;1058:140-150; 2005.